prostate cancer

Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug
Medical Marketing and Media
Thu, 05/24/18 - 05:39 pm
Sun Pharma
JNJ
Yonsa
prostate cancer
Zytiga
Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
Fierce Pharma
Wed, 05/23/18 - 10:24 pm
JNJ
prostate cancer
Zytiga
Sun Pharma
Yonsa
FDA
Additional Results from Phase I Study Show Inovio's INO-5150 Stabilizing Effect on Prostate Cancer
CP Wire
Fri, 05/18/18 - 09:57 am
Inovio
ASCO
prostate cancer
clinical trials
INO-5150
Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer
Xconomy
Wed, 05/9/18 - 09:45 am
Rapamycin Holdings
prostate cancer
rapamycin
NanOlogy Completes Dose Escalation Portion of Phase 2 Trial of Unique NanoPac for Prostate Cancer
CP Wire
Mon, 04/30/18 - 01:06 pm
NanOlogy
clinical trials
NanoPac
prostate cancer
NanOlogy Completes Dose Escalation Portion of Phase 2 Trial of Unique NanoPac for Prostate Cancer
Mon, 04/30/18 - 09:54 am
NanOlogy
NanoPac
prostate cancer
Qiagen launches liquid biopsy tests for lung, prostate cancer
Drug Delivery Business News
Sat, 04/14/18 - 12:43 pm
Qiagen
liquid biopsy
lung cancer
prostate cancer
diagnostics
AACR
Landmark study shows Opko 4Kscore test useful guide in choosing prostate cancer treatment options
CP Wire
Fri, 03/16/18 - 09:16 pm
OPKO Health
4Kscore
diagnostics
prostate cancer
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
J&J gets first-of-its-kind prostate cancer approval
Biopharma Dive
Wed, 02/14/18 - 11:48 pm
JNJ
apalutamide
prostate cancer
Strong data lift profile of J&J's cancer drug apalutamide
Biopharma Dive
Tue, 02/6/18 - 11:45 am
JNJ
apalutamide
prostate cancer
Pfizer, Astellas peg Xtandi expansion on PROSPER data
Biopharma Dive
Mon, 02/5/18 - 07:09 pm
Pfizer
Astellas
Xtandi
prostate cancer
Patent setback could sting J&J prostate cancer franchise
Biopharma Dive
Fri, 01/19/18 - 11:11 am
patents
JNJ
prostate cancer
Zytiga
Xtandi
Astellas
With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK
Endpoints
Thu, 01/18/18 - 10:00 am
Pfizer
JNJ
patents
Zytiga
Xtandi
prostate cancer
apalutamide
Bayer unblinds cancer drug study early to investigate patient deaths
BioPharma Dive
Fri, 12/1/17 - 12:20 pm
Bayer
clinical trials
Xofigo
prostate cancer
This drug may be able to treat both women’s health disorders and prostate cancer
Marketwatch
Thu, 10/12/17 - 09:31 am
Myovant
Relugolix
prostate cancer
uterine fibroids
endometriosis
J&J takes another big step forward with next-gen prostate cancer blockbuster apalutamide
Endpoints
Thu, 10/12/17 - 09:16 am
JNJ
prostate cancer
apalutamide
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal
Xconomy
Mon, 10/2/17 - 11:07 am
Endocyte
prostate cancer
ABX
PSMA-617
New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi
Endpoints
Thu, 09/14/17 - 10:27 am
Pfizer
Astellas
clinical trials
Xtandi
prostate cancer
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer

Pages